Search Result "GLP agonists."
GLP-1 Agonists and Satiety
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 8 Issue: 4 Year: 2008 Page: 311-316
Author(s): Nicholas T. Bello, Timothy H. Moran
Drug Design of GLP-1 Receptor Agonists: Importance of In Silico Methods
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 8 Year: 2021 Page: 1015-1024
Author(s): Smriti Sharma,Vinayak Bhatia
Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
Journal: Current Diabetes Reviews
Volume: 6 Issue: 4 Year: 2010 Page: 191-200
Author(s): Danilo Verge, Ximena Lopez
GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus
Journal: Current Diabetes Reviews
Volume: 16 Issue: 4 Year: 2020 Page: 279-292
Author(s): Lalita Dahiya,Ramandeep Kaur,Rajiv Kumar,Manoj Kumar,Kezia Palta
GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
Journal: Current Clinical Pharmacology
Volume: 7 Issue: 3 Year: 2012 Page: 214-228
Author(s): Giuseppe Derosa,Pamela Maffioli
Met-204 And Tyr-205 Are Together Important For Binding Glp-1 Receptor Agonists But Not Their N-Terminally Truncated Analogues
Journal: Protein & Peptide Letters
Volume: 11 Issue: 1 Year: 2004 Page: 15-22
Author(s): Rakel Lopez de Maturana, Janet Treece-Birch, Fatima Abidi, John B.C. Findlay, Dan Donnelly
The Discovery and Development of Glucagon-Like Peptide-1Receptor Agonists
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 20 Year: 2024 Page: 2921-2943
Author(s):
Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists
Journal: Current Diabetes Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 266-275
Author(s): Urd Kielgast, Jens J. Holst, Sten Madsbad
Role of Endogenous GLP-1 and its Agonists in Osteopenia and Osteoporosis: But We Little Know Until Tried
Journal: Current Diabetes Reviews
Volume: 10 Issue: 1 Year: 2014 Page: 43-47
Author(s): Athanasia Papazafiropoulou,Nikolaos Papanas,Stavros Pappas,Efstratios Maltezos
GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 2 Year: 2024 Page: 100-114
Author(s):